Year-over-year net earnings per share growth for the last 12 months: ICON Corp (ICLR)

Graphic logo of iconplc.com (ICLR)

ICON Public is optimizing data collection through cloud services and external laboratories. The quarterly EPS growth rate illustrates the effectiveness of this strategy, where 143.70 represents the current level of the metric. The company's revenues are based on comprehensive research management for global pharmaceutical behemoths. Multi-year agreements currently provide stability, although the impact of decentralized testing and biotech sector limits remain in focus.

ICON plc (ICLR) Year-over-year net earnings per share change for the last twelve months: for the period 07/04/2022 - 11/12/2026

Analytical breakdowns and data insights for company ICON Public (ICLR)

- market value and analyst target forecast:
Price Chart ICON Plc|ICLR - Analyst Median Target
- company stock exchange capitalization indicators:
Market Valuation ICON Plc|ICLR - Aggregate Business Value
- book capitalization indicators:
Net Assets per Single Share ICON|ICLR - Book Valuation of Business|Market Capitalization to Book Value Ratio iconplc.com|ICLR - Company Total Asset Base
- company total debt and liquidity indicators:
Total Debt to Capital ICON Public|ICLR - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity iconplc.com|ICLR - Company Cumulative Debt|Debt to Book Capitalization Ratio ICON Plc|ICLR - Company Long-Term Indebtedness|Company Current Liabilities ICON|Quick Liquidity iconplc.com
- earnings and market multiples details:
ICLR - Profit After Tax|Future Profit ICON Public|ICLR - P/E Multiple|Forward P/E Multiple ICON Public Limited Company|ICLR - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ICON Plc|ICLR - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) ICON|ICLR - Net earnings per share for the last four quarters|Quarterly EPS earnings growth iconplc.com|ICLR - Net earnings per share growth this year|Earnings growth forecast for next year ICON Public
Comprehensive company analysis:ICON Public
Flagship merchandise of iconplc.com

ICON Public revenues depend on the investment cycles of pharmaceutical corporations and the pace of clinical trials. This indicator captures the quarterly dynamics of earnings per share, reflecting the actual efficiency of the business. The metric allows investors to filter out market noise and identify a steady fundamental trend. It is crucial for investors to avoid impulsive decisions during sharp spikes. Analyze the quarterly change in earnings per share to assess long-term capital stability.

Key competitors

IQVIA (IQV) - Year-over-year earnings per share growth for the last twelve months|LH - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months MEDP|CRL (Charles River Corp) - Year-over-year earnings per share growth rate for the last twelve months|Year-over-year earnings per share growth for the last twelve months Evotec SE (EVO)|Year-over-year net earnings per share change for the last twelve months fortrea.com|Quarterly EPS earnings growth LFCR (Lifecore Biomedical, Inc.)|Year-over-year net earnings per share change for the last twelve months OmniAb Inc. (OABI)|Inotiv Corp - Quarterly EPS earnings growth|Avid Bioservices Inc (CDMO) - Year-over-year net earnings per share growth for the last 12 months|Catalent, Inc. (CTLT) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months nighthawkbio.com (SCPX)